Shaperon Inc

378800

Company Profile

  • Business description

    Shaperon Inc is a developer of innovative inflammasome inhibitors and nanobody therapeutics intended to develop novel treatments for various chronic inflammatory diseases, including atopic dermatitis, systemic inflammatory response syndrome, neuroinflammatory diseases, and chronic inflammation. It offers a range of drug candidates, including a gel-type atopic dermatitis drug for use in the treatment of systemic inflammatory response syndrome, neuroinflammatory diseases and for treating chronic inflammation. The company also provides immunotherapeutic products and a single-domain neutralizing antibody, enabling clients to improve patient’s quality of life by developing safe and efficacious drugs and immunotherapies.

  • Contact

    Gangnam Ace Tower G9
    Suie 218 & 606, 174-10 Jagok-ro, Gangnam-gu
    Seoul06373
    KOR

    T: +82 260838315

    http://www.shaperon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    53

Stocks News & Analysis

stocks

AI driving growth for ASX tech share

ASX tech share raises funds to facilitate customer AI spend.
stocks

OpenAI is going public as the worst value among its peers

Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks

Wide moat healthcare leader remains undervalued

ASX healthcare giant expected to see uptick in demand from emerging markets.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,824.8067.500.77%
CAC 408,288.2088.911.08%
DAX 4024,804.33188.110.76%
Dow JONES (US)51,232.00445.990.88%
FTSE 10010,347.7225.48-0.25%
HKSE24,565.9091.16-0.37%
NASDAQ26,226.28296.621.14%
Nikkei 22565,416.631,392.032.17%
NZX 50 Index13,204.08165.841.27%
S&P 5007,475.9870.250.95%
S&P/ASX 2008,604.2070.700.83%
SSE Composite Index4,010.0350.691.28%

Market Movers